Sinoway Industrial Co., Ltd.

Rivaroxaban 366789-02-8 Rivaroxaban 366789-02-8

Rivaroxaban 366789-02-8
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Rivaroxaban :

Name

Rivaroxaban

Alias

(S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;RIVAROXABAN STAGE-IV [5-CHLORO-N-({5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2(AS PER INV;Rivaroxaban Isomer;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;BAY 59-7939; 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide

CAS NO.

366789-02-8

Molecular Formula

C19H18ClN3O5S

Molecular Weight

435.88

Brief Introduction

Rivaroxaban is an oral, bioavailable Factor Xa inhibitor that selectively blocks the active site of Factor Xa and does not require a cofactor (eg, antithrombin III) to exert activity. Activation of factor X by factor Xa (FXa) by endogenous and exogenous pathways plays an important role in the coagulation cascade.

Rivaroxaban dose-dependently inhibits factor Xa activity in humans, with dose-dependent prolongation of prothrombin time (PT), activated partial thromboplastin time (aPTT), and HepTest® heparin quantitative determination using Neoplastin® reagent. Anti-factor Xa activity is also affected by rivaroxaban.

Storage condition

Room temperature, seal.


Use of Rivaroxaban:

Adult patients undergoing elective hip or knee replacement surgery to prevent venous thromboembolism (VTE)

COA of Rivaroxaban :

Items

Standard

Results

Appearance

White or almost white powder

White powder

Melting point

229~ 234℃

230.0~231.5℃

Residue on ignition

NMT0.1%

0.03%

Related substances


Any other impurity: NMT0.2%

Total of impurity: NMT0.5 %

0.1%

0.19%

Loss on drying

NMT1.0%

0.13%

Heavy metal

NMT20ppm

Conforms

Purity

More than 99.50%

99.81%

Conclusion: The results show that the product complies with the Enterprise standard.

* Products under the patent are only for R&D use.

  • Valsartan 137862-53-4
    Basic information of Valsartan:NameValsartanMolecular FormulaC24H29N5O3Molecular Weight435.52Quality StandardEP/USP/JPPackage Size25kg/drumBrief IntroductionValsartan (trade name Diovan) is an angiote... Valsartan 137862-53-4
  • Sitagliptin Phosphate 654671-78-0/654671-77-9
    Basic information of Sitagliptin:NameSitagliptinMolecular FormulaC16H15F6N5OMolecular Weight407.32 Quality StandardIn housePackage Size1kg/bag or according your requirementBrief IntroductionThis drug... Sitagliptin Phosphate 654671-78-0/654671-77-9
  • Lacosamide 175481-36-4
    Basic information of Lacosamide :NameLacosamideAlias(2R)-2-acetamido-N-benzyl-3-methoxy-propanamide;(2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide;ADD 243037;Erlosamide;Harkoseride;SPM 927... Lacosamide 175481-36-4
  • Esomeprazole Magnesium 217087-09-7
    Basic information:Other name: Esomeprazole magnesium trihydrate Bis(5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzylimidazole-1-yl) magnesium trihydrateCas no.: 217087-... Esomeprazole Magnesium 217087-09-7

MORE_DETAIL Rivaroxaban 366789-02-8

Basic information of Rivaroxaban :

Name

Rivaroxaban

Alias

(S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;RIVAROXABAN STAGE-IV [5-CHLORO-N-({5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2(AS PER INV;Rivaroxaban Isomer;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;BAY 59-7939; 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide

CAS NO.

366789-02-8

Molecular Formula

C19H18ClN3O5S

Molecular Weight

435.88

Brief Introduction

Rivaroxaban is an oral, bioavailable Factor Xa inhibitor that selectively blocks the active site of Factor Xa and does not require a cofactor (eg, antithrombin III) to exert activity. Activation of factor X by factor Xa (FXa) by endogenous and exogenous pathways plays an important role in the coagulation cascade.

Rivaroxaban dose-dependently inhibits factor Xa activity in humans, with dose-dependent prolongation of prothrombin time (PT), activated partial thromboplastin time (aPTT), and HepTest® heparin quantitative determination using Neoplastin® reagent. Anti-factor Xa activity is also affected by rivaroxaban.

Storage condition

Room temperature, seal.


Use of Rivaroxaban:

Adult patients undergoing elective hip or knee replacement surgery to prevent venous thromboembolism (VTE)

COA of Rivaroxaban :

Items

Standard

Results

Appearance

White or almost white powder

White powder

Melting point

229~ 234℃

230.0~231.5℃

Residue on ignition

NMT0.1%

0.03%

Related substances


Any other impurity: NMT0.2%

Total of impurity: NMT0.5 %

0.1%

0.19%

Loss on drying

NMT1.0%

0.13%

Heavy metal

NMT20ppm

Conforms

Purity

More than 99.50%

99.81%

Conclusion: The results show that the product complies with the Enterprise standard.

* Products under the patent are only for R&D use.
Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//